期刊
FUTURE SCIENCE OA
卷 8, 期 4, 页码 -出版社
FUTURE SCI LTD
DOI: 10.2144/fsoa-2021-0052
关键词
adjuvant; androgen deprivation therapy; androgen receptor; carcinoma; Her2/neu overexpression; parotid; patterns of care; radiotherapy; salivary duct; surgery
Salivary duct carcinoma (SDC) is a rare and aggressive malignancy. The optimal treatment protocols are debated. The study found that surgery and adjuvant radiation have positive effects on the survival of patients with SDC, and AR expression is associated with survival prognosis.
Aim: Salivary duct carcinoma (SDC) is a rare and aggressive malignancy. The optimal treatment protocols are debated. Methodology: A systematic search and individual patient data analysis of published cases of SDC was performed. SPSS v21 was used for statistical analysis. Results: Data of 857 patients available. Median overall survival (OS) and progression-free survival (PFS) of the entire cohort 42 months and 24 months. Nodal involvement, males, primary size >5 cm, androgen receptor (AR) negativity significantly worse OS. Patients with surgery had a favorable median PFS (p - 0.000) and OS (p - 0.077). Patients with adjuvant radiation had better PFS (30 vs 18 months; p = 0.077). Conclusion: SDC has modest survival. Surgery and adjuvant radiation should be advocated for all patients. AR expression appears prognostic for survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据